Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis?
Journal Title: Гастроентерологія - Year 2013, Vol 2, Issue 48
Abstract
The article displays current views on the process of fibrogenesis in patients with fatty liver disease. It is shown that steatosis and steatohepatitis are the main triggers of the process of fibrogenesis. Modern mechanisms of hepatic fibrosis were described. The issues of reversibility of fibrosis in liver diseases, particularly in fatty liver disease, are discussed. The main directions of antifibrotic therapy are shown. Administration of essential phospholipids in patients with hepatic steatosis and steatohepatitis with signs of fibrosis is appropriate from the perspective of evidence-based medicine. Enerliv® is a new generation of hepatoprotectors, it consists of fat-free soy phospholipids with a maximum degree of purity, and the concentration of phosphatidylcholine is an average of 76 % — a parameter unattainable for most preparations of essential phospholipids present in the domestic pharmaceutical market. Diffuse liver disease include membrane-associated defects and can proceed with the development of fibrosis, so the administration of phospholipids in a preparation Enerliv® can be considered as a basic therapy for fatty liver disease.
Authors and Affiliations
Yu. M. Stepanov, О. Yu. Filippova
Keywords
Related Articles
- EP ID EP229989
- DOI -
- Views 62
- Downloads 0
Functional Dyspepsia and Chronic Gastritis: Similarities and Differences
The article deals with is one of the most common symptoms, faced by general practitioners or gastroenterologists — functional dyspepsia. Its clinical manifestations are described, attention is paid to the treatment issue...
Activity of Adipokines and Inflammation in Development of Esophagitis in Overweight Patients with Gastroesophageal Reflux Disease
The aim of the study — to examine the role of adipokines (leptin, adiponectin) and markers of inflammation in the development of gastroesophageal reflux disease (GERD) in obesity. The study included 92 patients, of them...
Liver disorders in patients with ulcerative colitis
Background. The article deals with the chronic inflammatory bowel diseases, in particular, the attention is paid to ulcerative colitis (UC). UC proceeds with the development of a number of extraintestinal lesions, among...
Possibilities and Problems of Hepatoprotectors Application in Patients with Chronic Hepatitic C and Concomitamt Autoimmune Syndrome
A study of clinical and biochemical parameters of hepatoprotectors efficiency in 32 patients with chronic hepatitis C without signs of cirrhosis and with concomitant autoimmune component has been carried out. A significa...
Are Steatosis and Steatohepatitis Triggers of Hepatic Fibrogenesis?
The article displays current views on the process of fibrogenesis in patients with fatty liver disease. It is shown that steatosis and steatohepatitis are the main triggers of the process of fibrogenesis. Modern mechanis...